Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Recs

0
Player Avatar pchop123 (80.37) Submitted: 10/24/2013 4:59:12 PM : Outperform Start Price: $6.17 SVA Score: -11.96

Upside anything buy over

Featured Broker Partners


Advertisement